Accipiter Capital Management as of Dec. 31, 2010
Portfolio Holdings for Accipiter Capital Management
Accipiter Capital Management holds 29 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| WellPoint | 13.3 | $16M | 285k | 56.86 | |
| RehabCare | 9.5 | $12M | 490k | 23.70 | |
| Aetna | 8.7 | $11M | 349k | 30.51 | |
| Gilead Sciences (GILD) | 7.7 | $9.4M | 260k | 36.24 | |
| Orchid Cellmark | 6.4 | $7.8M | 3.9M | 1.98 | |
| BioMarin Pharmaceutical (BMRN) | 5.2 | $6.3M | 233k | 26.93 | |
| Service Corporation International (SCI) | 4.8 | $5.9M | 717k | 8.25 | |
| CIGNA Corporation | 4.5 | $5.5M | 150k | 36.66 | |
| Teva Pharmaceutical Industries (TEVA) | 4.5 | $5.4M | 104k | 52.13 | |
| Coventry Health Care | 4.3 | $5.3M | 200k | 26.40 | |
| Obagi Medical Products | 4.1 | $5.0M | 436k | 11.55 | |
| Hi-Tech Pharmacal | 4.0 | $4.8M | 194k | 24.95 | |
| Zimmer Holdings (ZBH) | 3.7 | $4.5M | 83k | 53.68 | |
| MAKO Surgical | 3.4 | $4.1M | 269k | 15.22 | |
| Health Management Associates | 2.9 | $3.6M | 376k | 9.54 | |
| RTI Biologics | 2.9 | $3.5M | 1.3M | 2.67 | |
| Covidien | 2.4 | $2.9M | 63k | 45.66 | |
| Quest Diagnostics Incorporated (DGX) | 2.2 | $2.7M | 50k | 53.96 | |
| Healthsouth | 2.2 | $2.7M | 129k | 20.71 | |
| Sequenom | 0.8 | $940k | 117k | 8.03 | |
| Cleveland BioLabs | 0.7 | $903k | 125k | 7.22 | |
| Dyax | 0.7 | $866k | 401k | 2.16 | |
| NeurogesX | 0.4 | $538k | 85k | 6.36 | |
| Cytori Therapeutics | 0.2 | $260k | 50k | 5.20 | |
| AVANIR Pharmaceuticals | 0.2 | $224k | 55k | 4.07 | |
| BioTime | 0.2 | $208k | 25k | 8.32 | |
| MELA Sciences | 0.1 | $115k | 34k | 3.34 | |
| MannKind Corporation | 0.1 | $81k | 10k | 8.10 | |
| PURE Bioscience | 0.0 | $11k | 5.0k | 2.20 |
